Page last updated: 2024-09-02

rx 821002 and hydroxyindoleacetic acid

rx 821002 has been researched along with hydroxyindoleacetic acid in 1 studies

Compound Research Comparison

Studies (rx 821002)	Trials (rx 821002)	Recent Studies (post-2010) (rx 821002)	Studies (hydroxyindoleacetic acid)	Trials (hydroxyindoleacetic acid)	Recent Studies (post-2010) (hydroxyindoleacetic acid)
317	0	45	8,911	322	594

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Schmidt, WJ; Srinivasan, J	1

Other Studies

1 other study(ies) available for rx 821002 and hydroxyindoleacetic acid

Article	Year
Treatment with alpha2-adrenoceptor antagonist, 2-methoxy idazoxan, protects 6-hydroxydopamine-induced Parkinsonian symptoms in rats: neurochemical and behavioral evidence. Behavioural brain research, 2004, Oct-05, Volume: 154, Issue:2 Topics: Adrenergic alpha-Antagonists; Analysis of Variance; Animals; Brain Chemistry; Catalepsy; Disease Models, Animal; Dopamine; Drug Interactions; Hydroxyindoleacetic Acid; Idazoxan; Male; Motor Activity; Norepinephrine; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Reaction Time; Serotonin; Statistics, Nonparametric	2004

Article

Year

Treatment with alpha2-adrenoceptor antagonist, 2-methoxy idazoxan, protects 6-hydroxydopamine-induced Parkinsonian symptoms in rats: neurochemical and behavioral evidence.

Behavioural brain research, 2004, Oct-05, Volume: 154, Issue:2

Topics: Adrenergic alpha-Antagonists; Analysis of Variance; Animals; Brain Chemistry; Catalepsy; Disease Models, Animal; Dopamine; Drug Interactions; Hydroxyindoleacetic Acid; Idazoxan; Male; Motor Activity; Norepinephrine; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Reaction Time; Serotonin; Statistics, Nonparametric

2004